Apoptosis, haemopoiesis and leukaemogenesis

被引:14
作者
Ekert, PG [1 ]
Vaux, DL [1 ]
机构
[1] CANC RES INST, NEW YORK, NY USA
来源
BAILLIERES CLINICAL HAEMATOLOGY | 1997年 / 10卷 / 03期
关键词
apoptosis; caspase; bcl-2; CD95; programmed cell death;
D O I
10.1016/S0950-3536(97)80026-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apoptosis, or physiological cell death, is the way in which unwanted cells are removed. The majority of cells formed during haemopoiesis are destined to die by apoptosis before they are fully differentiated, and homeostasis of cell number is maintained by a balance between mitosis and apoptosis. Many haematological malignancies are associated with changes in the number of cells undergoing apoptosis, which may be a direct or an indirect effect. Genetic mutations that prevent cell death cause cells to accumulate and can eventually lead to malignancy. Alternatively, oncogenic mutations that lead to increased cell production can indirectly cause a decrease in apoptosis in some populations and an increase in others. Chemotherapeutic drugs may kill cells directly, or indirectly by inducing apoptosis as a stress response. Therapeutic strategies are evolving to increase the propensity of malignant cells to die by either means and to mitigate side effects by reducing apoptosis in non-malignant cells.
引用
收藏
页码:561 / 576
页数:16
相关论文
共 69 条
[1]  
Alnemri ES, 1997, J CELL BIOCHEM, V64, P33, DOI 10.1002/(SICI)1097-4644(199701)64:1<33::AID-JCB6>3.0.CO
[2]  
2-0
[3]   Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice [J].
Amakawa, R ;
Hakem, A ;
Kundig, TM ;
Matsuyama, T ;
Simard, JJL ;
Timms, E ;
Wakeham, A ;
Mittruecker, HW ;
Griesser, H ;
Takimoto, H ;
Schmits, R ;
Shahinian, A ;
Ohashi, PS ;
Penninger, JM ;
Mak, TW .
CELL, 1996, 84 (04) :551-562
[4]  
BEDI A, 1994, BLOOD, V83, P2038
[5]   BCR-ABL-MEDIATED INHIBITION OF APOPTOSIS WITH DELAY OF G2/M TRANSITION AFTER DNA-DAMAGE - A MECHANISM OF RESISTANCE TO MULTIPLE ANTICANCER AGENTS [J].
BEDI, A ;
BARBER, JP ;
BEDI, GC ;
ELDEIRY, WS ;
SIDRANSKY, D ;
VALA, MS ;
AKHTAR, AJ ;
HILTON, J ;
JONES, RJ .
BLOOD, 1995, 86 (03) :1148-1158
[6]   THE CTLS KISS OF DEATH [J].
BERKE, G .
CELL, 1995, 81 (01) :9-12
[7]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[8]   CD40 LIGAND AND ITS ROLE IN X-LINKED HYPER-IGM SYNDROME [J].
CALLARD, RE ;
ARMITAGE, RJ ;
FANSLOW, WC ;
SPRIGGS, MK .
IMMUNOLOGY TODAY, 1993, 14 (11) :559-564
[9]   Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3 [J].
Chinnaiyan, AM ;
Hanna, WL ;
Orth, K ;
Duan, HJ ;
Poirier, GG ;
Froelich, CJ ;
Dixit, VM .
CURRENT BIOLOGY, 1996, 6 (07) :897-899
[10]   BCL-2 BLOCKS P53-DEPENDENT APOPTOSIS [J].
CHIOU, SK ;
RAO, L ;
WHITE, E .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (04) :2556-2563